Cell-based therapies for experimental chronic kidney disease: a systematic review and meta-analysis

被引:84
作者
Papazova, Diana A. [1 ]
Oosterhuis, Nynke R. [1 ]
Gremmels, Hendrik [1 ]
van Koppen, Arianne [1 ]
Joles, Jaap A. [1 ]
Verhaar, Marianne C. [1 ]
机构
[1] Univ Med Ctr Utrecht, Dept Hypertens & Nephrol, NL-3508 GA Utrecht, Netherlands
关键词
Cell-based therapy; Chronic kidney disease; Meta-analysis; MESENCHYMAL STEM-CELLS; ENDOTHELIAL PROGENITOR CELLS; BONE-MARROW-CELLS; INDUCED DIABETIC-NEPHROPATHY; CHRONIC-RENAL-FAILURE; STROMAL CELLS; ADIPOSE-TISSUE; RAT MODEL; INTERSTITIAL FIBROSIS; ISCHEMIA-REPERFUSION;
D O I
10.1242/dmm.017699
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Cell-based therapy is a promising strategy for treating chronic kidney disease (CKD) and is currently the focus of preclinical studies. We performed a systematic review and meta-analysis to evaluate the efficacy of cell-based therapy in preclinical (animal) studies of CKD, and determined factors affecting cell-based therapy efficacy in order to guide future clinical trials. In total, 71 articles met the inclusion criteria. Standardised mean differences (SMD) and 95% confidence intervals (CI) were calculated for outcome parameters including plasma urea, plasma creatinine, urinary protein, blood pressure, glomerular filtration rate, glomerulosclerosis and interstitial fibrosis. Sub-analysis for each outcome measure was performed for modelrelated factors (species, gender, model and timing of therapy) and cell-related factors (cell type, condition and origin, administration route and regime of therapy). Overall, meta-analysis showed that cellbased therapy reduced the development and progression of CKD. This was most prominent for urinary protein (SMD, 1.34; 95% CI, 1.00-1.68) and urea (1.09; 0.66-1.51), both P<0.001. Changes in plasma urea were associated with changes in both glomerulosclerosis and interstitial fibrosis. Sub-analysis showed that cell type (bone-marrow-derived progenitors and mesenchymal stromal cells being most effective) and administration route (intravenous or renal artery injection) were significant predictors of therapeutic efficacy. The timing of therapy in relation to clinical manifestation of disease, and cell origin and dose, were not associated with efficacy. Our meta-analysis confirms that cell-based therapies improve impaired renal function and morphology in preclinical models of CKD. Our analyses can be used to optimise experimental interventions and thus support both improved preclinical research and development of cell-based therapeutic interventions in a clinical setting. Disease Models & Mechanisms
引用
收藏
页码:281 / 293
页数:13
相关论文
共 93 条
[1]   Lineage-Negative Bone Marrow Cells Protect Against Chronic Renal Failure [J].
Alexandre, Cristianne Silva ;
Volpini, Rildo Aparecido ;
Shimizu, Maria Heloisa ;
Sanches, Talita Rojas ;
Semedo, Patricia ;
Di Jura, Vera Lucia ;
Camara, Niels Olsen ;
Seguro, Antonio Carlos ;
Andrade, Lucia .
STEM CELLS, 2009, 27 (03) :682-692
[2]   Intraparenchymal Injection of Bone Marrow Mesenchymal Stem Cells Reduces Kidney Fibrosis After Ischemia-Reperfusion in Cyclosporine-Immunosuppressed Rats [J].
Alfarano, C. ;
Roubeix, C. ;
Chaaya, R. ;
Ceccaldi, C. ;
Calise, D. ;
Mias, C. ;
Cussac, D. ;
Bascands, J. L. ;
Parini, A. .
CELL TRANSPLANTATION, 2012, 21 (09) :2009-2019
[3]   Effects of Mesenchymal Stem Cells Transplanted at Different Time Points in a Rat Remnant Kidney Model [J].
Bian, Xiaohui ;
Zhang, Beiru ;
Guo, Wei ;
Liu, Na ;
Bai, Yu ;
Miao, Jianing ;
Zhao, Guifeng ;
Liu, Bo ;
Wang, Shubao ;
Ma, Li ;
Zheng, Liqiang ;
Zhao, Yueyang ;
Li, Detian ;
Feng, Jiangmin .
AMERICAN JOURNAL OF NEPHROLOGY, 2014, 39 (01) :75-84
[4]  
Bohle A, 1996, KIDNEY INT, V49, pS2
[5]   Effect of whole bone marrow cell infusion in the progression of experimental chronic renal failure [J].
Caldas, H. C. ;
Fernandes, I. M. M. ;
Gerbi, F. ;
Souza, A. C. ;
Baptista, M. A. S. F. ;
Rarnalho, H. J. ;
Kawasaki-Oyama, R. S. ;
Goloni-Bertollo, E. M. ;
Pavarino-Bertelli, E. C. ;
Braile, D. M. ;
Abbud-Filho, M. .
TRANSPLANTATION PROCEEDINGS, 2008, 40 (03) :853-855
[6]   Effect of stem cells seeded onto biomaterial on the progression of experimental chronic kidney disease [J].
Caldas, Heloisa C. ;
Fernandes, Ida M. M. ;
Kawasaki-Oyama, Rosa S. ;
Baptista, Maria Alice S. F. ;
Plepis, Ana Maria G. ;
Martins, Virginia A. ;
Coimbra, Terezila M. ;
Goloni-Bertollo, Eny M. ;
Braile, Domingo M. ;
Abbud-Filho, Mario .
EXPERIMENTAL BIOLOGY AND MEDICINE, 2011, 236 (06) :746-754
[7]   Rationale of Mesenchymal Stem Cell Therapy in Kidney Injury [J].
Cantaluppi, Vincenzo ;
Biancone, Luigi ;
Quercia, Alessandro ;
Deregibus, Maria Chiara ;
Segoloni, Giuseppe ;
Camussi, Giovanni .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2013, 61 (02) :300-309
[8]   Failed renoprotection by alternatively activated bone marrow macrophages is due to a proliferation-dependent phenotype switch in vivo [J].
Cao, Qi ;
Wang, Yiping ;
Zheng, Dong ;
Sun, Yan ;
Wang, Changqi ;
Wang, Xin M. ;
Lee, Vincent W. S. ;
Wang, Ya ;
Zheng, Guoping ;
Tan, Thian K. ;
Wang, Yuan M. ;
Alexander, Stephen I. ;
Harris, David C. H. .
KIDNEY INTERNATIONAL, 2014, 85 (04) :794-806
[9]   Bone Marrow-Derived Mononuclear Cells Promote Improvement in Glomerular Function in Rats with Early Diabetic Nephropathy [J].
Castiglione, Raquel C. ;
Maron-Gutierrez, Tatiana ;
Barbosa, Carolina M. L. ;
Ornellas, Felipe M. ;
Barreira, Andre Luis ;
diBarros, Carolina B. A. ;
Vasconcelos-dos-Santos, Andreia ;
Paredes, Bruno Diaz ;
Pascarelli, Bernardo M. ;
Diaz, Bruno L. ;
Rossi-Bergmann, Bartira ;
Takiya, Christina M. ;
Rocco, Patricia R. M. ;
Souza-Menezes, Jackson ;
Morales, Marcelo M. .
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2013, 32 (03) :699-718
[10]   Mesenchymal Stem Cells Delivered at the Subcapsule of the Kidney Ameliorate Renal Disease in the Rat Remnant Kidney Model [J].
Cavaglieri, R. C. ;
Martini, D. ;
Sogayar, M. C. ;
Noronha, I. L. .
TRANSPLANTATION PROCEEDINGS, 2009, 41 (03) :947-951